0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Vascular Dilation and Tortuosity in Plus Disease FREE

Tammy L. Yanovitch, MD; Sharon F. Freedman, MD; David K. Wallace, MD, MPH
Arch Ophthalmol. 2009;127(1):109-116. doi:10.1001/archophthalmol.2008.527.
Text Size: A A A
Published online

Plus disease is the major factor in determining whether peripheral retinal ablation for retinopathy of prematurity is needed.1 Although the clinical definition of plus disease includes both dilation and tortuosity, previous reports have suggested that computer-based programs assessing tortuosity alone may be adequate to diagnose plus disease.24 The aim of this study was to determine the frequency of isolated dilation sufficient for plus disease (with insufficient tortuosity) and isolated plus-level tortuosity (with insufficient dilation) compared with the frequency of both plus-level dilation and plus-level tortuosity in a series of images.

In a previously published, institutional review board–approved study designed to compare the accuracy of computer-assisted image analysis using ROPtool with that of individual examiners, 6 pediatric ophthalmologists (S.F.F., Terri L. Young, MD, Laura B. Enyedi, MD, Graham E. Quinn, MD, Michael F. Chiang, MD, MA, and David K. Coats, MD) evaluated RetCam photographs of 190 different eyes from 117 premature infants.3 Of these photographs, 10 were excluded because of inadequate image quality as determined by one of us (D.K.W.) and 110 were excluded because they were determined to be without either dilation or tortuosity sufficient for plus disease by all of the experts. Therefore, a total of 70 images of 70 different eyes were included. The ophthalmologists independently scored each quadrant of each image by grading dilation and tortuosity separately (8 total grades per eye) as plus, preplus, or normal.

These scores were used to generate eye-level data. An eye-level grade of dilation (or tortuosity) sufficient for plus disease was present if at least 2 of the 4 quadrants in a single eye had dilation (or tortuosity) sufficient for plus disease. These grades were used to determine whether eyes had plus disease (2 quadrants of plus dilation and tortuosity), dilation sufficient but tortuosity insufficient for plus disease, tortuosity sufficient but dilation insufficient for plus disease, or dilation and tortuosity insufficient for plus disease. Thus, the reference standard for plus disease was dilation and tortuosity in the same 2 quadrants, which was the same definition used to define plus disease in both the Early Treatment for Retinopathy of Prematurity1 and Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity5 clinical trials. The same guideline was used for preplus disease, which we defined as in our previous studies3 as at least 2 quadrants of preplus dilation and tortuosity or worse.

For each ophthalmologist, the specificity of using dilation and tortuosity alone to diagnose plus disease was calculated, with both dilation and tortuosity as the reference standard. Therefore, each individual rater using only dilation or tortuosity was compared against himself or herself using both dilation and tortuosity. In this way, it was determined how often dilation was sufficient but tortuosity was insufficient for plus disease and how often tortuosity was sufficient but dilation was insufficient for plus disease (Figure). Specificity was calculated by dividing the number of eyes classified as not having plus disease as determined by dilation or tortuosity alone by the true number of eyes without plus disease as determined by dilation and tortuosity together. The identical analysis was also performed for the preplus level of disease or worse including the 70 images that were used in the plus analysis and the 110 images without dilation or tortuosity that were excluded from the plus analysis.

Place holder to copy figure label and caption
Figure.

Examples of RetCam photographs used for the study. A, Dilation sufficient but tortuosity insufficient for plus disease (image courtesy of Michael Chiang, MD, MA). B, Tortuosity sufficient but dilation insufficient for plus disease (image courtesy of PHOTO-ROP).

Graphic Jump Location

For plus disease, the specificities when using dilation alone for each consecutive grader were 71%, 95%, 83%, 87%, 48%, and 87% (mean, 79%; median, 87%). In comparison, the specificities when using tortuosity alone for each consecutive grader were 87%, 93%, 63%, 97%, 81%, and 83% (mean, 85%; median, 85%). For preplus disease, the specificities when using dilation alone were 74%, 96%, 83%, 74%, 19%, and 70% (mean, 71%; median, 75%), and the specificities when using tortuosity alone were 96%, 88%, 87%, 95%, 97%, and 95% (mean, 93%; median, 96%). The Table provides pooled frequency counts for eye-level analyses. Sensitivities were not calculated because they all equaled 100% by definition, ie, of those eyes with plus disease, all had dilation and tortuosity sufficient for plus disease.

Table Graphic Jump LocationTable. Pooled Frequency Counts for Eye-Level Analysesa

Although plus-level dilation and plus-level tortuosity usually appear together, it is not uncommon for eyes to exhibit dilation without tortuosity sufficient for plus disease or tortuosity without dilation sufficient for plus disease. Our data suggest that these scenarios occur with roughly equal frequency, so it is important to consider both dilation and tortuosity in plus disease. In addition, both dilation and tortuosity appear to be important in diagnosing preplus disease. Because we used quadrant-level grades to generate eye-level grades, a limitation of our study is that we cannot address the relative contribution of dilation and tortuosity to an examiner's overall impression (or gestalt) of plus disease. Our specific image set and disease definition may have affected the calculated specificities; however, the overall finding of the importance of both dilation and tortuosity remains consistent regardless of the precise numbers. These results have implications for the development of computer programs aimed at measuring plus disease and reducing subjectivity of its diagnosis.

ARTICLE INFORMATION

Correspondence: Dr Wallace, Duke University Eye Center, Box 3802, Duke University Medical Center, Durham, NC 27710-3802 (david.wallace@duke.edu).

Financial Disclosure: None reported.

Good  WVEarly Treatment for Retinopathy of Prematurity Cooperative Group, Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102233- 250
PubMed
Kylstra  JAFreedman  SFCapowski  JJHall  JG Measurement of retinal vessel tortuosity as a means of diagnosing plus disease in ROP [abstract]. Invest Ophthalmol Vis Sci 1995;36 (4) S18
Wallace  DKFreedman  SFZhao  ZJung  SH Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 2007;125 (11) 1523- 1530
PubMed Link to Article
Koreen  SGelman  RMartinez-Perez  M  et al.  Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology 2007;114 (12) e59- e67
PubMed Link to Article
STOP-ROP Multicenter Study Group, Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP): a randomized, controlled trial, I: primary outcomes. Pediatrics 2000;105 (2) 295- 310
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure.

Examples of RetCam photographs used for the study. A, Dilation sufficient but tortuosity insufficient for plus disease (image courtesy of Michael Chiang, MD, MA). B, Tortuosity sufficient but dilation insufficient for plus disease (image courtesy of PHOTO-ROP).

Graphic Jump Location

Tables

Table Graphic Jump LocationTable. Pooled Frequency Counts for Eye-Level Analysesa

References

Good  WVEarly Treatment for Retinopathy of Prematurity Cooperative Group, Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102233- 250
PubMed
Kylstra  JAFreedman  SFCapowski  JJHall  JG Measurement of retinal vessel tortuosity as a means of diagnosing plus disease in ROP [abstract]. Invest Ophthalmol Vis Sci 1995;36 (4) S18
Wallace  DKFreedman  SFZhao  ZJung  SH Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 2007;125 (11) 1523- 1530
PubMed Link to Article
Koreen  SGelman  RMartinez-Perez  M  et al.  Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology 2007;114 (12) e59- e67
PubMed Link to Article
STOP-ROP Multicenter Study Group, Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP): a randomized, controlled trial, I: primary outcomes. Pediatrics 2000;105 (2) 295- 310
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

363 Views
6 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis